author-photo

Claire Roddie

University College London

32

Papers

1337

Citations

Citation Trend

Filter By

Papers (25) Sort By

Journal Conference Others

Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial.

2021 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (1)
Tunable control of CAR T cell activity through tetracycline mediated disruption of protein-protein interaction.

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (0)
Early FDG PET response predicts CAR-T failure in large B-cell lymphoma.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Safety and Efficacy of AUTO1, a Fast-Off Rate CD19 CAR in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) and Chronic Lymphocytic Leukaemia (CLL)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti-CD19 CAR-T therapy: a case report

2021
Show All
- Source
- Cite
- Save
Citations (0)
National implementation of the use of tisagenlecleucel in paediatric and young adult patients with acute lymphoblastic leukaemia (ALL) in National Health Service England (NHSE)

2020
Show All
- Source
- Cite
- Save
Citations (0)
Steroid Use, Advanced Stage Disease and ≥3 Lines of Prior Chemotherapy Are Associated with a Higher Risk of Infection Following CD19 CAR T-Cell Therapy for B-NHL: Real World Data from a Large UK Center

2020 Blood
Show All
- Source
- Cite
- Save
Citations (2)
A primer set for the rapid isolation of scFv fragments against cell surface antigens from immunised rats.

2020 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (1)
Intention to Treat Analysis of Real-World Outcomes Following Tisgenlecleucel Therapy for Pediatric and Young Adult ALL through a National Access Programme

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)